Jeffrey R. Petrella

Jeffrey R. Petrella

Neuroradiology

2301 Erwin Rd
Durham, NC 27705

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

One Hundred Cerebral Microhemorrhages: Rethinking Cerebral Amyloid Angiopathy in the Era of Amyloid-Targeted Antibodies.

One Hundred Cerebral Microhemorrhages: Rethinking Cerebral Amyloid Angiopathy in the Era of Amyloid-Targeted Antibodies.

Journal: Cureus

Published: March 12, 2026

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.

Journal: CNS drugs

Published: November 10, 2025

Identifiability-Guided Assessment of Digital Twins in Alzheimer's Disease Clinical Research and Care.

Identifiability-Guided Assessment of Digital Twins in Alzheimer's Disease Clinical Research and Care.

Journal: bioRxiv : the preprint server for biology

Published: September 02, 2025

Artificial Intelligence-Assisted Detection of Amyloid-Related Imaging Abnormalities: Promise and Pitfalls.

Artificial Intelligence-Assisted Detection of Amyloid-Related Imaging Abnormalities: Promise and Pitfalls.

Journal: AJNR. American journal of neuroradiology

Published: June 18, 2025

AI-Assisted Detection of Amyloid-related Imaging Abnormalities (ARIA): Promise and Pitfalls.

AI-Assisted Detection of Amyloid-related Imaging Abnormalities (ARIA): Promise and Pitfalls.

Journal: AJNR. American journal of neuroradiology

Published: June 18, 2025

Erratum for: MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum.

Erratum for: MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum.

Journal: Radiology

Published: May 27, 2025

Data-Driven Modeling of Amyloid-beta Targeted Antibodies for Alzheimer's Disease.

Data-Driven Modeling of Amyloid-beta Targeted Antibodies for Alzheimer's Disease.

Journal: Research square

Published: April 16, 2025

Predicting risk of impending cognitive decline in asymptomatic individuals with early Alzheimer's disease: Insights from cortical diffusion MRI.

Predicting risk of impending cognitive decline in asymptomatic individuals with early Alzheimer's disease: Insights from cortical diffusion MRI.

Journal: Imaging neuroscience (Cambridge, Mass.)

Published: April 08, 2025

Harnessing artificial intelligence to transform Alzheimer's disease research.

Harnessing artificial intelligence to transform Alzheimer's disease research.

Journal: Nature medicine

Published: April 01, 2025

Data-driven modeling of amyloid-β targeted antibodies for Alzheimer's disease.

Data-driven modeling of amyloid-β targeted antibodies for Alzheimer's disease.

Journal: NPJ systems biology and applications

Published: March 27, 2025

Correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer's disease and amnestic mild cognitive impairment.

Correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer's disease and amnestic mild cognitive impairment.

Journal: BMC ophthalmology

Published: February 26, 2025

Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.

Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.

Journal: GeroScience

Published: September 06, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026